Centogene N.V.

NASDAQ:CNTG

0.33 (USD) • At close January 16, 2025
Bedrijfsnaam Centogene N.V.
Symbool CNTG
Munteenheid USD
Prijs 0.325
Beurswaarde 9,425,033
Dividendpercentage 0%
52-weken bereik 0.14 - 1.53
Industrie Diagnostics & Research
Sector Healthcare
CEO Ms. Kim Stratton
Website https://www.centogene.com

An error occurred while fetching data.

Over Centogene N.V.

Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository,

Vergelijkbare Aandelen

Eyenovia, Inc. logo

Eyenovia, Inc.

EYEN

1.09 USD

Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc.

GALT

1.32 USD

Augmedix, Inc. logo

Augmedix, Inc.

AUGX

2.345 USD

Viracta Therapeutics, Inc. logo

Viracta Therapeutics, Inc.

VIRX

0.022 USD

Journey Medical Corporation logo

Journey Medical Corporation

DERM

7.47 USD

BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp.

BCTX

5.2 USD

Minerva Surgical, Inc. logo

Minerva Surgical, Inc.

UTRS

0 USD

HCW Biologics Inc. logo

HCW Biologics Inc.

HCWB

6.9 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)